Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Canadian guideline for Parkinson disease.

Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M, Suchowersky O, Rajput A, Lafontaine AL, Mestre T, Appel-Cresswell S, Kalia SK, Schoffer K, Zurowski M, Postuma RB, Udow S, Fox S, Barbeau P, Hutton B.

CMAJ. 2019 Sep 9;191(36):E989-E1004. doi: 10.1503/cmaj.181504. No abstract available.

PMID:
31501181
2.

Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison.

Holden SK, Koljack CE, Prizer LP, Sillau SH, Miyasaki JM, Kluger BM.

Parkinsonism Relat Disord. 2019 Jun 23. pii: S1353-8020(19)30281-0. doi: 10.1016/j.parkreldis.2019.06.018. [Epub ahead of print]

PMID:
31253494
3.

Framing advance care planning in Parkinson disease: Patient and care partner perspectives.

Lum HD, Jordan SR, Brungardt A, Ayele R, Katz M, Miyasaki JM, Hall A, Jones J, Kluger B.

Neurology. 2019 May 28;92(22):e2571-e2579. doi: 10.1212/WNL.0000000000007552. Epub 2019 Apr 26.

PMID:
31028124
4.

Does outpatient palliative care improve patient-centered outcomes in Parkinson's disease: Rationale, design, and implementation of a pragmatic comparative effectiveness trial.

Kluger BM, Katz M, Galifianakis N, Pantilat SZ, Kutner JS, Sillau S, Gritz M, Jones J, Fairclough D, Sumrall M, Hall K, Miyasaki J.

Contemp Clin Trials. 2019 Apr;79:28-36. doi: 10.1016/j.cct.2019.02.005. Epub 2019 Feb 16.

PMID:
30779960
5.

Reader response: Demoralization in Parkinson disease.

Bruno V, Mancini D, Zurowski M, Miyasaki JM.

Neurology. 2018 Nov 27;91(22):1029. doi: 10.1212/WNL.0000000000006568. No abstract available.

PMID:
30478072
6.

Age and sex differences in burnout, career satisfaction, and well-being in US neurologists.

LaFaver K, Miyasaki JM, Keran CM, Rheaume C, Gulya L, Levin KH, Jones EC, Schwarz HB, Molano JR, Hessler A, Singhal D, Shanafelt TD, Sloan JA, Novotny PJ, Cascino TL, Busis NA.

Neurology. 2018 Nov 13;91(20):e1928-e1941. doi: 10.1212/WNL.0000000000006497. Epub 2018 Oct 10.

PMID:
30305448
7.

Readability of advance directive documentation in Canada: a cross-sectional study.

Richard A, Richard J, Johnston W, Miyasaki J.

CMAJ Open. 2018 Sep 28;6(3):E406-E411. doi: 10.9778/cmajo.20180037. Print 2018 Jul-Sep.

8.

Top Ten Tips Palliative Care Clinicians Should Know About Parkinson's Disease and Related Disorders.

Katz M, Goto Y, Kluger BM, Galifianakis NB, Miyasaki JM, Kutner JS, Jones CA, Pantilat SZ.

J Palliat Med. 2018 Oct;21(10):1507-1517. doi: 10.1089/jpm.2018.0390. Epub 2018 Sep 11.

PMID:
30204543
9.

A Mixed-Methods Approach to Understanding the Palliative Needs of Parkinson's Patients.

Prizer LP, Gay JL, Wilson MG, Emerson KG, Glass AP, Miyasaki JM, Perkins MM.

J Appl Gerontol. 2018 May 1:733464818776794. doi: 10.1177/0733464818776794. [Epub ahead of print]

PMID:
29788783
10.

Author response: Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016.

Miyasaki JM, Rheaume C, Gulya L, Ellenstein A, Schwarz H, Vidic T, Shanafelt T, Cascino T, Keran C, Busis N.

Neurology. 2018 May 8;90(19):903. doi: 10.1212/WNL.0000000000005487. No abstract available.

PMID:
29735774
11.

The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?

Chou KL, Stacy M, Simuni T, Miyasaki J, Oertel WH, Sethi K, Fernandez HH, Stocchi F.

Parkinsonism Relat Disord. 2018 Jun;51:9-16. doi: 10.1016/j.parkreldis.2018.02.001. Epub 2018 Feb 2. Review.

PMID:
29456046
12.

Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease.

Bruno V, Freitas ME, Mancini D, Lui JP, Miyasaki J, Fox SH.

Can J Neurol Sci. 2018 Jan;45(1):23-29. doi: 10.1017/cjn.2017.245.

PMID:
29334040
13.

Implementation issues relevant to outpatient neurology palliative care.

Kluger BM, Persenaire MJ, Holden SK, Palmer LT, Redwine H, Berk J, Anderson CA, Filley CM, Kutner J, Miyasaki J, Carter J.

Ann Palliat Med. 2018 Jul;7(3):339-348. doi: 10.21037/apm.2017.10.06. Epub 2017 Nov 29.

14.

Author response: Burnout, career satisfaction, and well-being among US neurologists in 2016.

Busis NA, Shanafelt TD, Keran CM, Levin KH, Schwarz HB, Molano JR, Vidic TR, Kass JS, Miyasaki JM, Sloan JA, Cascino TL.

Neurology. 2017 Oct 10;89(15):1650-1651. doi: 10.1212/WNL.0000000000004484. Epub 2017 Oct 9. No abstract available.

PMID:
28993531
15.

Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016.

Miyasaki JM, Rheaume C, Gulya L, Ellenstein A, Schwarz HB, Vidic TR, Shanafelt TD, Cascino TL, Keran CM, Busis NA.

Neurology. 2017 Oct 17;89(16):1730-1738. doi: 10.1212/WNL.0000000000004526. Epub 2017 Sep 20.

PMID:
28931640
16.

Treatable inherited rare movement disorders.

Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM; International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders.

Mov Disord. 2018 Jan;33(1):21-35. doi: 10.1002/mds.27140. Epub 2017 Sep 1. Review.

17.

Treatment gaps in Parkinson's disease care in the Philippines.

Jamora RDG, Miyasaki JM.

Neurodegener Dis Manag. 2017 Aug;7(4):245-251. doi: 10.2217/nmt-2017-0014. Epub 2017 Aug 30. Review.

PMID:
28853633
18.

Using social exchange theory to understand non-terminal palliative care referral practices for Parkinson's disease patients.

Prizer LP, Gay JL, Perkins MM, Wilson MG, Emerson KG, Glass AP, Miyasaki JM.

Palliat Med. 2017 Oct;31(9):861-867. doi: 10.1177/0269216317701383. Epub 2017 Mar 22.

PMID:
28659011
19.

Palliative Care and Parkinson's Disease: Caregiver Perspectives.

Boersma I, Jones J, Coughlan C, Carter J, Bekelman D, Miyasaki J, Kutner J, Kluger B.

J Palliat Med. 2017 Sep;20(9):930-938. doi: 10.1089/jpm.2016.0325. Epub 2017 May 18.

20.

Decisional capacity for advanced care directives in Parkinson's disease with cognitive concerns.

Abu Snineh M, Camicioli R, Miyasaki JM.

Parkinsonism Relat Disord. 2017 Jun;39:77-79. doi: 10.1016/j.parkreldis.2017.03.006. Epub 2017 Mar 8.

PMID:
28336349
21.

Burnout, career satisfaction, and well-being among US neurologists in 2016.

Busis NA, Shanafelt TD, Keran CM, Levin KH, Schwarz HB, Molano JR, Vidic TR, Kass JS, Miyasaki JM, Sloan JA, Cascino TL.

Neurology. 2017 Feb 21;88(8):797-808. doi: 10.1212/WNL.0000000000003640. Epub 2017 Jan 25.

22.

Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research.

Kluger BM, Fox S, Timmons S, Katz M, Galifianakis NB, Subramanian I, Carter JH, Johnson MJ, Richfield EW, Bekelman D, Kutner JS, Miyasaki J.

Parkinsonism Relat Disord. 2017 Apr;37:19-26. doi: 10.1016/j.parkreldis.2017.01.008. Epub 2017 Jan 11. Review.

PMID:
28108265
23.

Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.

Bruno VA, Fox SH, Mancini D, Miyasaki JM.

Can J Neurol Sci. 2016 Sep;43(5):697-702. doi: 10.1017/cjn.2016.279. Epub 2016 Aug 12.

PMID:
27514242
24.

Treatment of Advanced Parkinson Disease and Related Disorders.

Miyasaki JM.

Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1104-16. doi: 10.1212/CON.0000000000000347. Review.

PMID:
27495200
25.

New insights into the neural basis of functional movement disorders.

Planetta PJ, Miyasaki JM.

Neurology. 2016 Aug 9;87(6):554-5. doi: 10.1212/WNL.0000000000002957. Epub 2016 Jul 6. No abstract available.

PMID:
27385748
26.

Parkinson disease patients' perspectives on palliative care needs: What are they telling us?

Boersma I, Jones J, Carter J, Bekelman D, Miyasaki J, Kutner J, Kluger B.

Neurol Clin Pract. 2016 Jun;6(3):209-219.

27.

Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary.

Factor SA, Bennett A, Hohler AD, Wang D, Miyasaki JM.

Neurology. 2016 Jun 14;86(24):2278-83. doi: 10.1212/WNL.0000000000002670. Epub 2016 May 11. No abstract available.

28.

High prevalence of physical and sexual aggression to caregivers in advanced Parkinson's disease. Experience in the Palliative Care Program.

Bruno V, Mancini D, Ghoche R, Arshinoff R, Miyasaki JM.

Parkinsonism Relat Disord. 2016 Mar;24:141-2. doi: 10.1016/j.parkreldis.2016.01.010. Epub 2016 Jan 11. No abstract available.

PMID:
26786755
29.

Author response.

Kluger BM, Miyasaki J.

Neurology. 2015 Mar 17;84(11):1184. No abstract available.

PMID:
25941728
30.

Palliative care for Parkinson's disease: has the time come?

Miyasaki JM, Kluger B.

Curr Neurol Neurosci Rep. 2015 May;15(5):26. doi: 10.1007/s11910-015-0542-4. Review.

PMID:
25795037
31.

The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond.

Hassan A, Wu SS, Schmidt P, Simuni T, Giladi N, Miyasaki JM, Bloem BR, Malaty IA, Okun MS.

J Parkinsons Dis. 2015;5(2):313-9. doi: 10.3233/JPD-140515.

PMID:
25720446
32.

Palliative care and neurology: time for a paradigm shift.

Boersma I, Miyasaki J, Kutner J, Kluger B.

Neurology. 2014 Aug 5;83(6):561-7. doi: 10.1212/WNL.0000000000000674. Epub 2014 Jul 2. Review.

33.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
34.

Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians.

Mestre TA, Teodoro T, Reginold W, Graf J, Kasten M, Sale J, Zurowski M, Miyasaki J, Ferreira JJ, Marras C.

Parkinsonism Relat Disord. 2014 Jun;20(6):608-12. doi: 10.1016/j.parkreldis.2014.03.001. Epub 2014 Mar 12.

PMID:
24661467
35.

Movement disorders in pregnancy.

Miyasaki JM, Aldakheel A.

Continuum (Minneap Minn). 2014 Feb;20(1 Neurology of Pregnancy):148-61. doi: 10.1212/01.CON.0000443842.18063.a9. Review.

PMID:
24492816
36.

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

Nutt JG, Siderowf AD, Guttman M, Schmidt PN, Zamudio JI, Wu SS, Okun MS, Simuni T, Parashos SA, Dahodwala NA, Davis TL, Giladi N, Gurevich T, Hauser RA, Jankovic J, Lyons KE, Marsh L, Miyasaki JM, Morgan JC, Santiago AJ, Tarsy D, Mari Z, Malaty IA, Nelson EC; National Parkinson Foundation Quality Improvement Initiative Investigators.

Parkinsonism Relat Disord. 2014 Mar;20(3):274-9. doi: 10.1016/j.parkreldis.2013.10.004. Epub 2013 Oct 16.

PMID:
24182524
37.

Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions.

Antonelli F, Ko JH, Miyasaki J, Lang AE, Houle S, Valzania F, Ray NJ, Strafella AP.

Hum Brain Mapp. 2014 Jun;35(6):2499-506. doi: 10.1002/hbm.22344. Epub 2013 Sep 3.

38.

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice.

Keller A, Westenberger A, Sobrido MJ, García-Murias M, Domingo A, Sears RL, Lemos RR, Ordoñez-Ugalde A, Nicolas G, da Cunha JE, Rushing EJ, Hugelshofer M, Wurnig MC, Kaech A, Reimann R, Lohmann K, Dobričić V, Carracedo A, Petrović I, Miyasaki JM, Abakumova I, Mäe MA, Raschperger E, Zatz M, Zschiedrich K, Klepper J, Spiteri E, Prieto JM, Navas I, Preuss M, Dering C, Janković M, Paucar M, Svenningsson P, Saliminejad K, Khorshid HR, Novaković I, Aguzzi A, Boss A, Le Ber I, Defer G, Hannequin D, Kostić VS, Campion D, Geschwind DH, Coppola G, Betsholtz C, Klein C, Oliveira JR.

Nat Genet. 2013 Sep;45(9):1077-82. doi: 10.1038/ng.2723. Epub 2013 Aug 4.

PMID:
23913003
39.

Palliative care in Parkinson's disease.

Miyasaki JM.

Curr Neurol Neurosci Rep. 2013 Aug;13(8):367. doi: 10.1007/s11910-013-0367-y.

PMID:
23761129
40.

Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Mestre TA, Strafella AP, Thomsen T, Voon V, Miyasaki J.

Ther Adv Neurol Disord. 2013 May;6(3):175-88. doi: 10.1177/1756285613476127.

41.

Author Response.

Armstrong MJ, Miyasaki J.

Neurology. 2013 Mar 5;80(10):970. No abstract available.

PMID:
23580968
42.

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Suchowersky O, Armstrong MJ, Miyasaki J.

Neurology. 2013 Mar 5;80(10):970. doi: 10.1212/WNL.0b013e3182885eb3. No abstract available.

PMID:
23460621
43.

Which dyskinesia scale best detects treatment response?

Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S.

Mov Disord. 2013 Mar;28(3):341-6. doi: 10.1002/mds.25321. Epub 2013 Feb 6.

PMID:
23390076
44.

The emerging field of palliative care for Parkinson's disease. Letter from the guest editors.

Miyasaki JM, Okun MS.

Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S1. doi: 10.1016/j.parkreldis.2012.10.012. No abstract available.

PMID:
23206368
45.

Canadian Guidelines on Parkinson's Disease.

Grimes D, Gordon J, Snelgrove B, Lim-Carter I, Fon E, Martin W, Wieler M, Suchowersky O, Rajput A, Lafontaine AL, Stoessl J, Moro E, Schoffer K, Miyasaki J, Hobson D, Mahmoudi M, Fox S, Postuma R, Kumar H, Jog M; Canadian Nourological Sciences Federation.

Can J Neurol Sci. 2012 Jul;39(4 Suppl 4):S1-30. No abstract available.

PMID:
23126020
46.

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.

Pondal M, Marras C, Miyasaki J, Moro E, Armstrong MJ, Strafella AP, Shah BB, Fox S, Prashanth LK, Phielipp N, Lang AE.

J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):130-5. doi: 10.1136/jnnp-2012-302684. Epub 2012 Aug 29.

PMID:
22933817
47.

Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD.

Miyasaki JM, Long J, Mancini D, Moro E, Fox SH, Lang AE, Marras C, Chen R, Strafella A, Arshinoff R, Ghoche R, Hui J.

Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S6-9. doi: 10.1016/j.parkreldis.2012.06.013. Epub 2012 Aug 3.

PMID:
22867994
48.

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.

Armstrong MJ, Miyasaki JM; American Academy of Neurology.

Neurology. 2012 Aug 7;79(6):597-603. doi: 10.1212/WNL.0b013e318263c443. Epub 2012 Jul 18.

49.

What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study.

Hassan A, Wu SS, Schmidt P, Malaty IA, Dai YF, Miyasaki JM, Okun MS.

Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S10-4. doi: 10.1016/j.parkreldis.2012.06.014. Epub 2012 Jul 7.

PMID:
22776044
50.

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, Antonelli F, Houle S, Lang AE, Strafella AP.

Neurobiol Dis. 2012 Dec;48(3):519-25. doi: 10.1016/j.nbd.2012.06.021. Epub 2012 Jul 3.

Supplemental Content

Loading ...
Support Center